418 related articles for article (PubMed ID: 23404859)
21. Epigenetic biomarkers in lung cancer.
Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
[TBL] [Abstract][Full Text] [Related]
22. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer.
Markou A; Liang Y; Lianidou E
Clin Chem Lab Med; 2011 Oct; 49(10):1591-603. PubMed ID: 21767219
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
Wang Q; Wang S; Wang H; Li P; Ma Z
Exp Biol Med (Maywood); 2012 Mar; 237(3):227-35. PubMed ID: 22345301
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
Zen K; Zhang CY
Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
[TBL] [Abstract][Full Text] [Related]
27. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
[TBL] [Abstract][Full Text] [Related]
28. Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients.
Keller A; Backes C; Leidinger P; Kefer N; Boisguerin V; Barbacioru C; Vogel B; Matzas M; Huwer H; Katus HA; Stähler C; Meder B; Meese E
Mol Biosyst; 2011 Dec; 7(12):3187-99. PubMed ID: 22027949
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs: a new key in lung cancer.
Zhang Y; Yang Q; Wang S
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1105-11. PubMed ID: 25135624
[TBL] [Abstract][Full Text] [Related]
30. Prognostic immune markers in non-small cell lung cancer.
Suzuki K; Kachala SS; Kadota K; Shen R; Mo Q; Beer DG; Rusch VW; Travis WD; Adusumilli PS
Clin Cancer Res; 2011 Aug; 17(16):5247-56. PubMed ID: 21659461
[TBL] [Abstract][Full Text] [Related]
31. Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer.
Yao Q; Zhang AM; Ma H; Lin S; Wang XX; Sun JG; Chen ZT
Mol Cell Probes; 2012 Oct; 26(5):182-7. PubMed ID: 22796123
[TBL] [Abstract][Full Text] [Related]
32. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD.
Leidinger P; Keller A; Borries A; Huwer H; Rohling M; Huebers J; Lenhof HP; Meese E
Lung Cancer; 2011 Oct; 74(1):41-7. PubMed ID: 21388703
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs in breast cancer pathogenesis.
Götte M
Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
[TBL] [Abstract][Full Text] [Related]
36. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.
Masuda K; Takano A; Oshita H; Akiyama H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2011 Dec; 17(24):7712-22. PubMed ID: 22016508
[TBL] [Abstract][Full Text] [Related]
37. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
38. [Circulating microRNAs in lung cancer: prospects for diagnostics, prognosis and prediction of antitumor treatment efficiency].
Vlasov VV; Rykova EIu; Ponomareva AA; Zaporozhchenko IA; Morozkin ES; Cherdyntseva NV; Laktionov PP
Mol Biol (Mosk); 2015; 49(1):55-66. PubMed ID: 25916110
[TBL] [Abstract][Full Text] [Related]
39. Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer.
Mozzoni P; Banda I; Goldoni M; Corradi M; Tiseo M; Acampa O; Balestra V; Ampollini L; Casalini A; Carbognani P; Mutti A
Biomarkers; 2013 Dec; 18(8):679-86. PubMed ID: 24102090
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
